AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2007
Aug 10, 2007
30339_dirs_2007-08-10_1b079527-0aec-4744-9ad5-3c99722ddf78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-08-09
Reporting Person: YOUNG ROBERT C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-08-09 | Common Stock | M | 1932 | $19.3650 | Acquired | 11032.0000 | Direct |
| 2007-08-09 | Common Stock | F | 932 | $40.1500 | Disposed | 10100.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-08-09 | Stock Option (Right to Buy) | $19.3650 | M | 1932 | Disposed | 2015-05-05 | Common Stock (1932.0000) | Direct |
Footnotes
F1: Purchased option shares through a net exercise by directing the Company to retain as payment from the total exercise cost sufficient shares of Common Stock that would otherwise have been received upon this exercise and received the net balance in option shares.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27